Zobrazeno 1 - 10
of 20
pro vyhledávání: '"F. I. Nagimova"'
Autor:
G. R. Khasanova, S. T. Agliullina, L. M. Mukharyamov, F. I. Nagimova, G. N. Khasanova, Kh. S. Khaertynov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 19, Iss 4, Pp 30-37 (2020)
Relevance. The development of the HIV epidemic in different parts of the word is accompanied by the dynamics of its manifestations, including a change in the role in epidemics of various routes of transmission, “risky groups” and shifts in the ge
Externí odkaz:
https://doaj.org/article/de245421cde3433db29d49b169bb6196
Autor:
A. V. Kravchenko, N. V. Sizova, S. V. Minaeva, O. A. Kozyrev, F. I. Nagimova, O. S. Efremova, D. A. Gusev, E. V. Ovsyannikova
Publikováno v:
Журнал инфектологии, Vol 11, Iss 1, Pp 33-40 (2019)
The aim of the study was to assess the efficacy and safety of ART regimens that included different doses of the drug 6НР with the reception of QD, in comparison with the scheme of ART, containing, PhAZT, to select the daily dose 6НР in conducting
Externí odkaz:
https://doaj.org/article/67538076bf734a378f62ddf13116a4ed
Autor:
A. V. Kravchenko, E. A. Orlova-Morozova, T. E. Shimonova, O. A. Kozyrev, F. I. Nagimova, N. G. Zaharova, E. S. Ivanova, U. A. Kuimova, A. A. Popova, O. E. Chernova, O. S. Tonkih, D. A. Gusev, A. A. Yakovlev, V. V. Pokrovsky, V. V. Bychko, N. V. Vostokova
Publikováno v:
Журнал инфектологии, Vol 10, Iss 2, Pp 76-82 (2018)
A randomized multicenter 96-week study of an elsulfavirine (ESV), non-nucleoside reverse transcriptase inhibitor (NNRTI) of novel generation, in combination with 2 nucleoside/ nucleotide reverse transcriptase inhibitors (NRTIs) was conducted in naive
Externí odkaz:
https://doaj.org/article/ccd16d06c41c4c1cac7a9639593806e6
Autor:
D. A. Gusev, S. A. Buzunova, A. A. Yakovlev, V. B. Musatov, L. V. Glyzhina, S. A. Bykov, E. A. Strebkova, F. I. Nagimova, T. N. Bulatova, O. N. Kononchuk, R. G. Yapparov, S. V. Zajcev, V. N. Zapol’skaja, O. E. Chernova, Yu. K. Plotnikova, V. Yu. Rozenberg, E. I Mironova, M. G. Katjagina
Publikováno v:
Журнал инфектологии, Vol 9, Iss 3, Pp 40-45 (2017)
Objective: Evaluation of CVD and their risk factors in Russian 40+ HIV-infected patients is a key objective of the study. Materials and Methods: A retrospective analysis of 1872 medical records of 40+ HIV-infected patients from 12 regions of Russia o
Externí odkaz:
https://doaj.org/article/9c140c4e354c4473a9c6453a4026802c
Autor:
O. O. Znoyko, M. V. Maevskaya, E. A. Klimova, S. L. Maksimov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Publikováno v:
Журнал инфектологии, Vol 5, Iss 1, Pp 83-90 (2014)
Algeron (cepeginterferon alfa-2b) is a new pegylated form of interferon alfa containing linear polyethylene glycol (molecular weight 20 kDa). Pharmacokinetic profile of Algeron allows once weekly administration. In phase II–III study 150 treatment-
Externí odkaz:
https://doaj.org/article/8309c85f05cb4ce69fe7e97dad55ad44
Autor:
M. V. Mayevskaya, O. O. Znoyko, Ye. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, Yu. N. Linkova
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 24, Iss 2, Pp 53-64 (2014)
Aim of investigation. Comparative study of efficacy and safety of Algeron in dozes of 1,5 and 2,0 mkg/kg and PegIntron in combination to ribavirin within combined mode of treatment of patients with chronic hepatitis C (CHC) with subsequent assessment
Externí odkaz:
https://doaj.org/article/669a8954f13c48a996ee55f26090f58f
Autor:
M. V. Mayevskaya, O. O. Znoyko, E. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 23, Iss 1, Pp 30-36 (2013)
Aim of the study. To compare efficacy and safety of Algeron 1.5 and 2.0 μg/kg with PegIntron in combination with ribavirin in the treatment of chronic hepatitis C and to determine therapeutic dose of Algeron.Materials and Methods. 150 adult treatmen
Externí odkaz:
https://doaj.org/article/ba56af4b112c4c51b8bd662454878759
Publikováno v:
Fundamental and Clinical Medicine. 7:31-41
Aim. To assess the frequency of late HIV diagnosis among newly diagnosed HIV cases in 2019 and to determine associated risk factors.Materials and Methods. The study included data from 1073 adult patients who lived in the Tatarstan Republic and were f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d907d288196fcb29069ba751e7cdbfa
https://doi.org/10.23946/2500-0764-2022-7-1-31-41
https://doi.org/10.23946/2500-0764-2022-7-1-31-41
Autor:
O. A. Kozyrev, D. A. Gusev, A. V. Kravchenko, E. V. Ovsyannikova, F. I. Nagimova, S. V. Minaeva, O. S. Efremova, N. V. Sizova
Publikováno v:
Žurnal Infektologii, Vol 11, Iss 1, Pp 33-40 (2019)
The aim of the study was to assess the efficacy and safety of ART regimens that included different doses of the drug 6НР with the reception of QD, in comparison with the scheme of ART, containing, PhAZT, to select the daily dose 6НР in conducting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b7bf1b4c8bc2f573e9ed89d221e4a2
https://doi.org/10.22625/2072-6732-2019-11-1-33-40
https://doi.org/10.22625/2072-6732-2019-11-1-33-40
Autor:
O. V. Zozulya, O. A. Kozyrev, O. S. Efremova, E. A. Orlova-Morozova, U. A. Kuimova, E. S. Ivanova, D. B. Sonin, N. G. Zakharova, F. I. Nagimova, V. V. Bichko, N. V. Kurina, A. V. Kravchenko, T. E. Shimonova, O. S. Tonkikh, V. V. Pokrovsky, A. A. Yakovlev, O. E. Chernova, N. V. Vostokova
Publikováno v:
Infekcionnye bolezni. 15:5-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d08673da6422300d2c19d3348ba53098
https://doi.org/10.20953/1729-9225-2017-3-5-13
https://doi.org/10.20953/1729-9225-2017-3-5-13